← All trials
NCT03979898
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 15, 2017
- Primary completion
- Apr 23, 2019
- Completion date
- May 13, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 1
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- R-BiopharmLead sponsor
- Kyung Hee UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.